Peer Review History
| Original SubmissionJuly 31, 2025 |
|---|
|
Please submit your revised manuscript by Jan 07 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.... We look forward to receiving your revised manuscript. Kind regards, Leonard Ighodalo Uzairue, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why. 3. We noticed you have some minor occurrence of overlapping text with the following previous publication(s), which needs to be addressed: https://pdfs.semanticscholar.org/9e43/7517937937eb2d3e5b30178ad9c741781997.pdf https://www.liebertpub.com/doi/10.1089/fpd.2021.0059 In your revision ensure you cite all your sources (including your own works), and quote or rephrase any duplicated text outside the methods section. Further consideration is dependent on these concerns being addressed. 4. Thank you for stating in your Funding Statement: “This work was partially supported by the BAS-USDA Program in Agriculture and Life Sciences [grant number BAS-USDA PALS LS-18] and Ministry of Science and Technology of Bangladesh [grant number SRG-221102].” Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 5. Thank you for stating the following financial disclosure: “This work was partially supported by the BAS-USDA Program in Agriculture and Life Sciences [grant number BAS-USDA PALS LS-18] and Ministry of Science and Technology of Bangladesh [grant number SRG-221102]. “ Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 6. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 7. We note that Figure 1, 5 and 6 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: 1. You may seek permission from the original copyright holder of Figure 1, 5 and 6 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” 2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ 8. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels. In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: General Comments This manuscript addresses an important and timely topic, namely the prevalence of ESBL-producing and carbapenem-resistant E. coli and Salmonella spp. in poultry meat and live bird market (LBM) sewage in Bangladesh. The study is ambitious, covering all eight divisions of the country, and provides valuable epidemiological data with direct relevance for food safety and antimicrobial resistance (AMR) surveillance. The paper is methodologically sound, but the manuscript is lengthy, data-heavy, and at times repetitive. The clarity of presentation can be improved by streamlining results, tightening the introduction and discussion, and emphasizing the key public health implications. Specific comments are provided below. Specific Comments Abstract Well done, it is recommended that only the main prevalence figures and key results be highlighted. Introduction Well contextualized, but partially repetitive (antibiotic misuse, poultry as reservoir). Condense to improve flow. Explicitly state the knowledge gap: previous studies in Bangladesh were fragmented, this is the first comprehensive survey covering all divisions. Methods Sampling design is solid but justification for “5 samples per LBM” should be added. Clarify whether clustering effects (design effect) were considered in sample size calculation. Provide more detail on the positive and negative controls used in PCR assays. Results Results are highly detailed, with many percentages. Consider moving some data to supplementary materials. Figures and maps are informative but crowded; merging or simplifying some would enhance readability. Report confidence intervals along with prevalence estimates. Discussion The discussion is well written, but could perhaps be improved by better comparing more recent studies, if available, from South/South-East Asia and Africa. Perhaps a clearer distinction could be made between explanations based on concrete evidence (e.g. the use of antibiotics) and more speculative interpretations. Discuss in more detail the feasibility of the proposed interventions (antibiotic management, LBM sanitation services) in the context of Bangladesh. Conclusion The conclusions appear appropriate. Nevertheless, it would be advisable to include, among the practical recommendations, the strengthening of biosecurity measures throughout all stages of production and the implementation of stricter drug control. Such measures are consistent with practices adopted in other production systems, where antimicrobials are administered exclusively following a veterinary diagnosis and several active substances are restricted from use in livestock production. Grammatical or stylistic corrections Line 55- in the medical, veterinary and agriculture sectors.. correct in... medical, veterinary, and agricultural sectors. Line 57-58 - ...through faces or manure... feces” (non “faces”). Line 59-61 - ...and it is anticipated to climb by 67% by 2030 in rapidly polluting and developing countries around the world.... shorten the thought type.....and is projected to rise by 67% by 2030, particularly in rapidly developing countries.” Line 64–67-“However, the chicken industry's fast expansion, combined with widespread and frequently uncontrolled antibiotic usage, has contributed to the spread of MDR bacteria across the food chain.” Better .. “The rapid expansion of the chicken industry, combined with uncontrolled antibiotic usage, has facilitated the spread of MDR bacteria through the food chain”. Line 86-87 ...E. coli and Salmonella spp., that produces ESBLs, and demonstrates MDR, has implications...” correct in... “that produce ESBLs and demonstrate MDR have implications...” Line 93–94 - “...have demonstrated alarming levels of resistance...” better..high levels (eliminate alarming). Line 109–110 - “...possible hotspot for ESBL-producing and carbapenem resistant bacteria to humans.” Better “hotspot for transmission ... to humans.” Line 523 ....were MDR..” there is a double point Line 526–535 -“The occurrence of high MDR and existance of pXDR among ESBL-producing and CR-E. coli and Salmonella spp. could be due to widespreed and unrestricted use of antibiotics during poultry production in Bangladesh as well as low levels of waste management system, which increases selective pressure for MDR bacteria, thus facilitating the emergence and dissemination of MDR foodborne bacteria in poultry production system and retail poultry products.” The sentence is too long. It should be split into at least two clauses. Line 531–532 .....high MDR and existance of pXDR.... correct as “existence”. Line 533....widespreed and unrestricted use... correct as “widespread”. Line 555...ESBL-prodicing...” correct as .“producing”. Line 606–608 “The drug regularity authority of Bangladesh should develop an implementable monitoring and evaluation system to tackle this issue. Besides, alternative therapies should be explored and assessed for treating and preventing multidrug resistant bacterial infections.” The sentence can be made more fluid: “The Bangladesh drug regulatory authority should implement effective monitoring systems, and alternative therapies should be explored to treat and prevent MDR infections.”. drug regularity authority of Bangladesh...correct as “drug regulatory authority...” Reviewer #2: Comments to authors: The current study is interesting and clearly describes the findings with strong methedology; however, the authors are recommended to address the following comments to improve the overall quality of the manuscript: Abstract Clear and well-written Introduction 1. Check for punctuation errors throughout the manuscript (double space, eg, line 60, comma eg. line 65) 2. Line 69. Among MDR strains, foodborne pathogens, especially Escherichia coli (E. coli) ____. The abbreviation should be introduced in the sentences above before using the short form 3. Line 82. Please cross-check that all scientific gene names are written correctly throughout the manuscript, eg. if CTX-M has to be in subscript format (blaCTX-M) Method and material 4. Line 136-137. A cross-sectional live bird market (LBM) survey was carried out on 64 LBMs of 32 upazilas in 16 districts (second tier of administrative regions) of Bangladesh. For better clarity, it is recommended to rewrite the sentence. Here are the suggested revisions: A cross-sectional survey of live bird markets (LBM) was conducted in 64 LBM locations across 32 upazilas in 16 districts (the second tier of administrative regions) of Bangladesh 5. Line 154-155. Prior to collection of samples, the informed consent was taken from the chicken’s seller. I recommend rewriting this sentence, here is the suggested: Prior to the collection of samples, informed consent was taken from the chicken seller. 6. Line 212-213. The presence of ESBLs-encoding genes (blaCTX-M-1, and blaCTX-M-2) in ESBL-producing E. coli and Salmonella spp. isolates was determined by duplex PCR using specific oligonucleotide primers[35] Question. 1. Why did you choose to screen only these ESBL genes? Why not include blaTEM and blaSHV as well? Question. 2. Why did you choose to screen only one Cr gene? 7. line 230-231.………… commercially available imipenem (10 µg) and meropenem (10 µg) disks. Isolates that were resistant to at least one carbapenem drug were considered as CR isolates[34, 36], ….. These sentences contain wording errors and should be corrected: disk must be disks, …….on=one 8. Line 236-239. The PCR reaction mixtures of 25 µL total volume containing 12.5 µL of OneTaq® Quick-Load® 2X PCR Master Mix with standard buffer (New England, BioLabs Inc.), 8.5 µL water, 1 µL template DNA from each isolate, and 1.5 µL from each primer with a concentration of 15 pmol. For better clarity, these sentences should be rewritten. You may consider the following suggested revisions. The PCR reaction mixtures, with a total volume of 25 µL, contained 12.5 µL of OneTaq® Quick-Load® 2X PCR Master Mix with standard buffer (New England Biolabs Inc.), 8.5 µL of water, 1 µL of template DNA from each isolate, and 1.5 µL of each primer at a concentration of 15 pmol. Result 9. Line 316-317. The carbapenemase gene, blaNDM-1, was detected in 5.2% (9/173) isolates of CR-E. coli and 33.6% (40/119) isolates of CR-Salmonella spp Suggested correction The carbapenemase gene, blaNDM-1, was detected in 5.2% (9/173) of CR-E. coli isolates and 33.6% (40/119) isolates of CR-Salmonella spp. 10. Line 391-393. Isolates of ESBL-E. coli (40.6% and 21%) and Salmonella spp. (34.5% and 22.3%), as well as CR-E. coli (42.8% and 21.4%) and Salmonella spp. (42.9% and 25.2%) recovered from retail chicken meat, exhibited resistance to 9–12 and 5–8 antimicrobial agents, respectively These sentences are unclear. What do the two percentages in one bracket represent (e.g., 40.6% and 21%; 34.5% and 22.3%)? Please rewrite them to avoid confusion for readers. Discussion 11. Line 486. Interestingly, the blaCTX-M-2 gene was only detected in a single (2%) E. coli Instead of using a word single … only one, suggested correction. Interestingly, the blaCTX-M-2 gene was detected in only one (2%) E. coli 12. Line 516-518. Since different LBMs are anticipated to use different management techniques while slaughtering of chickens, and processing of chicken meat, there are varying hazards Suggested corrections. Since different LBMs are anticipated to use different management techniques during the slaughter of chickens and processing of chicken meat, varying hazards are associated with the presence of CR-E. coli and Salmonella spp 13. Line 570-571 Additionally, Bangladesh should control the use of antibiotics in poultry in order to reduce the levels of resistance found in the current study. Suggested correction. Additionally, Bangladesh should regulate the use of antibiotics in poultry to reduce the levels of resistance found in the current study. 14. In the discussion section, please include the public health implications of the high prevalence of MDR, ESBL-producing E. coli and Salmonella spp., as well as carbapenem-resistant E. coli and Salmonella spp. detected in sewage samples, and explain their potential role in disseminating antimicrobial resistance (AMR) into the environment ********** what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..--> Reviewer #1: No Reviewer #2: Yes: Mulu Lemlem DestaMulu Lemlem DestaMulu Lemlem DestaMulu Lemlem Desta ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 1 |
|
Distribution of ESBL-producing and carbapenem-resistant E. coli and Salmonella spp. in retail chicken meat and live bird market sewage in Bangladesh PONE-D-25-41667R1 Dear Dr. Islam, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.... If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Leonard Ighodalo Uzairue, PhD Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: (No Response) ********** Reviewer #1: Distribution of ESBL-producing and carbapenem-resistant E. coli and Salmonella spp. in retail chicken meat and live bird market sewage in Bangladesh General Comment The research examines numerous live bird markets and their respective wastewaters in Bangladesh. The authors investigated the presence of antibiotic-resistant bacteria, specifically E. coli and Salmonella spp, in both retail chicken meat and sewage effluent. The findings reveal a high prevalence of these species, particularly those exhibiting multidrug resistance (MDR), including resistance to last-resort antibiotics such as carbapenems. As the authors rightly highlight, these results underscore the urgent need for action by health authorities to limit antibiotic use in livestock and to improve hygiene and biosecurity measures within Bangladesh's live poultry markets. The authors employed both classical and molecular methods, which successfully addressed the objectives outlined in the introduction. The results are interpreted and discussed correctly. Following the revisions made to the manuscript, the paper is now suitable for publication without further changes. ********** what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..--> Reviewer #1: Yes: Dr. Guido GrilliDr. Guido GrilliDr. Guido GrilliDr. Guido Grilli ********** |
| Formally Accepted |
|
PONE-D-25-41667R1 PLOS One Dear Dr. ISLAM, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Leonard Ighodalo Uzairue Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .